Navigation Links
FIRMAGON® Results in Fast, Long-Term Suppression of Testosterone in Prostate Cancer Patients Without Initial Testosterone Surge
Date:6/1/2010

RMAGON® was shown to be non - inferior to leuprolide in sustaining castrate levels of testosterone from Days 28 – 364. This trial formed the primary basis for the successful Food and Drug Administration (FDA) approval of FIRMAGON® in December, 2008.  The study results showed that at day 3 of treatment, 96% of FIRMAGON® patients achieved castrate levels of testosterone, compared with zero percent receiving leuprolide. The median testosterone level with FIRMAGON® treatment was sustained at <9 ng/dL with no initial testosterone surge or microsurge following maintenance injections throughout the one-year study.

More About FIRMAGON

FIRMAGON is administered monthly by subcutaneous injection.  The starting dose is 240 mg, followed by monthly maintenance doses of 80 mg.  FIRMAGON is available for order through traditional and specialty pharmacy distributors.  The average monthly cost of one year of FIRMAGON treatment is comparable to other hormone treatments for prostate cancer.

Important Safety Information

FIRMAGON is contraindicated in patients with known hypersensitivity to degarelix or to any of the product components.  FIRMAGON is not indicated in women or pediatric patients.  Long-term androgen deprivation therapy prolongs the QT interval.  Physicians should consider whether the benefits of ADT outweigh the potential risks in patients with congenital long QT syndrome, electrolyte abnormalities, or congestive heart failure and in patients taking Class IA (e.g. quinidine, procainamide) or Class III (e.g. amiodarone, sotalol) antiarrhythmic medications. The most commonly observed adverse reactions during FIRMAGON therapy included injection site reactions (e.g. pain, erythema, swelling or induration), hot flashes, increased weight, fatigue, and increases in serum level
'/>"/>

SOURCE Ferring Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Extension Study With FIRMAGON® (degarelix) Showed Continued Benefits for Prostate Cancer Patients Beyond One Year
2. Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its Third Quarter Ended April 30, 2010
3. Elbit Imaging Ltd. Announces First Quarter Results for 2010
4. The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbotts Carotid Stent System and Surgery
5. Abbotts Groundbreaking Bioresorbable Technology Continues to Demonstrate Exceptional Clinical Results
6. Abbotts Investigational MitraClip(R) System Demonstrates Strong Safety Results and Improved Clinical Outcomes for Common Causes of Leaky Heart Valves
7. AcelRx Announces Positive Phase 2 Results From a Study of ARX-02 Sufentanil NanoTab(TM) Breakthrough Pain Management System in Treating Cancer Breakthrough Pain
8. China Yongxin Pharmaceuticals Reports First Quarter 2010 Financial Results
9. Bayer HealthCare Pharmaceuticals, Inc. Announces Results of a Phase 3 Clinical Trial of Gadobutrol
10. Concord Medical to Report First Quarter 2010 Financial Results on Thursday, May 27, 2010
11. China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014 Germany Gynecological ... GlobalData,s new report, "Germany Gynecological Devices Market ... the Germany Gynecological Devices market. The report provides ... units) and average prices (in US dollars) within ... Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips ...
(Date:9/17/2014)... NEW YORK , Sept. 17, 2014 ... of PDL BioPharma, Inc. ("PDL BioPharma" or the "Company") ... Robert S. Willoughby at rswilloughby@pomlaw.com or ... PDL BioPharma and certain of its officers and/or directors ... Exchange Act of 1934.  On September ...
(Date:9/17/2014)... 17, 2014 Bronstein, Gewirtz & Grossman, LLC ... the securities of PDL BioPharma, Inc. ("PDL BioPharma" or ... investors are advised to contact Peretz Bronstein ... at info@bgandg.com or 212-697-6484. The ... its executives violated federal securities laws. On ...
Breaking Medicine Technology:Germany Gynecological Devices Market Outlook to 2020 2Germany Gynecological Devices Market Outlook to 2020 3SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PDL BioPharma, Inc. - PDLI 2Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Investigates claims on behalf of Investors of PDL BioPharma, Inc. --PDLI 2
(Date:9/18/2014)... September 18, 2014 Specialty Teleradiology ... Westlake, OH, announces that they have achieved Meaningful ... a Complete Certified Ambulatory EHR-certified system developed by ... Teleradiology had a non MU compliant PACS and ... business grew from a niche in oncology to ...
(Date:9/17/2014)... 18, 2014 Recently, BambooIndustry.com, an outstanding company ... bamboo floorings . There are more than 1000 items ... launched a big promotion for these useful items. Each of ... % off. , “We are very proud to unveil ... say, all these items are made with natural materials by ...
(Date:9/17/2014)... IntimateRider, an inventor of classy sexual enhancement ... it has entered into a dealership agreement with new ... reason for the deal is the fact that All ... its sales potential, representatives at the mobility products firm ... latest products on the market both nationally and internationally." ...
(Date:9/17/2014)... (PRWEB) September 18, 2014 US medical ... tons of medical waste in 2014. Due to public ... in landfills along with municipal solid waste. An increasing ... regulated medical waste (RMW). This includes disposable items that ... potentially infectious materials. As a result of increased regulation, ...
(Date:9/17/2014)... 2014 As kinship care continues to ... cannot live with their parents, emphasis on kinship care ... enhance services and supports for kinship caregivers and families. ... Kinship Care Conference is being held this week in ... practice, policy, program and service development for kinship caregivers, ...
Breaking Medicine News(10 mins):Health News:Specialty Teleradiology Attains Meaningful Use with PowerServer MU 2Health News:Specialty Teleradiology Attains Meaningful Use with PowerServer MU 3Health News:More Than 1000 Items Added To BambooIndustry.com’s Bamboo Flooring Collection 2Health News:IntimateRider Announces All Terrain Medical & Mobility as Its New Dealer 2Health News:IntimateRider Announces All Terrain Medical & Mobility as Its New Dealer 3Health News:Medical Waste Disposal Services in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Medical Waste Disposal Services in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Arizona’s Children Association Kinship Service Providers Invited to Present at the CWLA National Conference 2
... 7 Perot Systems,Corporation (NYSE: PER ) ... it acquired in August 2007, will fully transition ... toward full,integration. Perot Systems will now refer to ... its ability to access the global information,technology provider,s ...
... announced today that Immediate Past President and public,health leader ... home outside,East Lansing, Michigan. He was diagnosed with pancreatic ... served as the 162nd,president of the AMA from June ... on,preventive medicine and had been a longtime public health ...
... by a tumor or injury carry a severe psychological and ... in plastic surgery. Helmut Fischer and Wolfgang Gubisch present the ... of Deutsches rzteblatt International ( Dtsch Arztebl Int ... a woman who had had a tumor removed from the ...
... to bone marrow transplantation pioneered in part by a ... to be the only safe and effective cure for ... Lakshmanan Krishnamurti, MD, a pediatric hematologist/oncologist at Children,s Hospital, ... relies on reduced-intensity conditioning (RIC). RIC regimens are less ...
... Allscripts-Misys Healthcare,Solutions, Inc. (formerly named Allscripts Healthcare Solutions, ... ("Allscripts") and,headquartered in Chicago, Illinois announced today its ... Convertible Senior Debentures due 2024 (the,"Debentures") at a ... to 100% of the principal amount of the ...
... - Nearly 700 health plans evaluated based on ... 7 U.S. News Media Group and The,National ... fourth,annual edition of America,s Best Health Plans on ... millions of Americans prepare to,select their healthcare coverage, ...
Cached Medicine News:Health News:Perot Systems Announces Name Change of JJWild 2Health News:Perot Systems Announces Name Change of JJWild 3Health News:AMA Immediate Past President Ron Davis Loses Battle With Cancer, Leaves Enduring AMA and Public Health Legacy 2Health News:AMA Immediate Past President Ron Davis Loses Battle With Cancer, Leaves Enduring AMA and Public Health Legacy 3Health News:Children's Hospital study demonstrates how bone marrow transplant can cure sickle cell disease 2Health News:Allscripts Announces Notice of Offer to Purchase in Cash 3.50% Convertible Senior Debentures due 2024 2Health News:Allscripts Announces Notice of Offer to Purchase in Cash 3.50% Convertible Senior Debentures due 2024 3Health News:Allscripts Announces Notice of Offer to Purchase in Cash 3.50% Convertible Senior Debentures due 2024 4Health News:U.S. News Media Group and NCQA Release 2008 Rankings for America's Best Health Plans 2Health News:U.S. News Media Group and NCQA Release 2008 Rankings for America's Best Health Plans 3